StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) operating KPIs

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca respiratory & Immunology (R&I) — Established RoW product sales ($M) ($M)

Form 6-K / 20-F Therapy Area Product Sales Table

QuarterlyAnnual
Latest, Q2 2026
226
Period ended Jun 30, 2026
Change on a year earlier
+8.7%
208 in Q2 2025
History
23 quarters
Since Q4 2020
Sources
23
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRespiratory & Immunology (R&I) — Established RoW product sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026226+8.7%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 2026207+18.3%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025218+14.7%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 2025202+15.4%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 2025208+20.2%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 2025175+17.4%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 2024190+11.8%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 2024175+13.6%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 2024173+8.1%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 2024149+5.7%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 2023170+9.7%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 2023154+3.4%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 2023160+0.6%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 2023141-6.0%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 2022155-4.9%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 2022149-6.3%Form 6-K FY2022Q3 Earnings Release ↗

Breakdown

What makes up respiratory & immunology (r&i) — established row product sales ($m)

Cite this data

StockData. (2026). AstraZeneca Respiratory & Immunology (R&I) — Established RoW product sales ($M) ($M), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/ta_ri_erow

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.